EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII

Blood

Volumn 115, Issue 5, 2010, Pages 1081-1087

  Zheng, Chunlei ^a   Liu, Hui Hui ^a   Zhou, Jiahai ^b   Zhang, Bin ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; CALCIUM ION; ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT PROTEIN 53; MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2; PROTEIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 8; CALCIUM; LMAN1 PROTEIN, HUMAN; MANNOSE BINDING LECTIN; MCFD2 PROTEIN, HUMAN; MEMBRANE PROTEIN; VESICULAR TRANSPORT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; EF HAND DOMAIN; ENDOPLASMIC RETICULUM; GENE DELETION; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; PROTEIN MOTIF;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CERCOPITHECUS AETHIOPS; CIRCULAR DICHROISM; COS CELLS; EF HAND MOTIFS; FACTOR V; FACTOR VIII; HUMANS; IMMUNOPRECIPITATION; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; TRANSFECTION; VESICULAR TRANSPORT PROTEINS;

EID: 77649229333     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-241877     Document Type: Article

References (31)

1. Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost. 2009;35(4):390-399.
2. Zhang B, Ginsburg D. Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. J Thromb Haemost. 2004;2(9):1564-1572.
3. Zhang B. Recent developments in the understanding of the combined deficiency of FV and FVIII. Br J Haematol. 2009;145(1):15-23.
4. Nichols WC, Seligsohn U, Zivelin A, et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell. 1998;93(1): 61-70.
5. Zhang B, Cunningham MA, Nichols WC, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet. 2003; 34(2):220-225.
6. Arar C, Carpentier V, Le Caer JP, Monsigny M, Legrand A, Roche AC. ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi intermediate compartment, is identical to MR60, an intracellular mannose-specific lectin of myelomonocytic cells. J Biol Chem. 1995;270(8): 3551-3553.
7. Itin C, Roche AC, Monsigny M, Hauri HP. ERGIC-53 is a functional mannose-selective and calcium-dependent human homologue of leguminous lectins. Mol Biol Cell. 1996;7(3):483-493.
8. Itin C, Kappeler F, Linstedt AD, Hauri HP. A novel endocytosis signal related to the KKXX ER-retrieval signal. EMBO J. 1995;14(10):2250-2256.
9. Kappeler F, Klopfenstein DR, Foguet M, Paccaud JP, Hauri HP. The recycling of ERGIC-53 in the early secretory pathway: ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII. J Biol Chem. 1997; 272(50):31801-31808.
10. Nufer O, Kappeler F, Guldbrandsen S, Hauri HP. ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains. J Cell Sci. 2003;116(21):4429-4440.
11. Neve EP, Lahtinen U, Pettersson RF. Oligomerization and intracellular localization of the glycoprotein receptor ERGIC-53 is independent of disulfide bonds. J Mol Biol. 2005;354(3):556-568.
12. Zhang B, Kaufman RJ, Ginsburg D. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem. 2005;280(27):25881-25886.
13. Zhang B, Spreafico M, Yang A, et al. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. Blood. 2008;111(12): 5592-5600.
14. Velloso LM, Svensson K, Schneider G, Pettersson RF, Lindqvist Y. Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a protein involved in glycoprotein export from the endoplasmic reticulum. J Biol Chem. 2002; 15979-15984.
15. Velloso LM, Svensson K, Pettersson RF, Lindqvist Y. The crystal structure of the carbohydrate-recognition domain of the glycoprotein sorting receptor p58/ ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J Mol Biol. 2003;334(5):845-851.
16. Hauri HP, Kappeler F, Andersson H, Appenzeller C. ERGIC-53 and traffic in the secretory pathway. J Cell Sci. 2000;113(4):587-596.
17. Bonifacino JS, Glick BS. The mechanisms of vesicle budding and fusion. Cell. 2004;116(2): 153-166.
18. Lee MC, Miller EA. Molecular mechanisms of COPII vesicle formation. Semin Cell Dev Biol. 2007;18(4):424-434.
19. Guy JE, Wigren E, Svard M, Hard T, Lindqvist Y. New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2. J Mol Biol. 2008;381(4):941-955.
20. Manavalan P, Johnson WC. Sensitivity of circular-dichroism to protein tertiary structure class. Nature. 1983;305(5937):831-832.
21. Nyfeler B, Kamiya Y, Boehlen F, et al. Deletion of three residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. Blood. 2007;111(3):1299-1301.
22. Spreafico M, Peyvandi F. Combined FV and FVIII deficiency. Haemophilia. 2008;14(6):1201-1208.
23. Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J Mol Biol. 2006;359(3):509-525.
24. Nyfeler B, Zhang B, Ginsburg D, Kaufman RJ, Hauri HP. Cargo selectivity of the ERGIC-53/ MCFD2 transport receptor complex. Traffic. 2006; 7(11):1473-1481.
25. Kawasaki N, Ichikawa Y, Matsuo I, et al. The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood. 2008;111(4): 1972-1979.
26. Anelli T, Ceppi S, Bergamelli L, et al. Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J. 2007;26(19):4177-4188.
27. Appenzeller C, Andersson H, Kappeler F, Hauri HP. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol. 1999;1(6): 330-334.
28. Mattioli L, Anelli T, Fagioli C, Tacchetti C, Sitia R, Valetti C. ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. J Cell Sci. 2006;119(Pt 12):2532-2541.
29. Morais VA, Brito C, Pijak DS, et al. N-glycosylation of human nicastrin is required for interaction with the lectins from the secretory pathway calnexin and ERGIC-53. Biochim Biophys Acta. 2006;1762(9): 802-810.
30. Nyfeler B, Reiterer V, Wendeler MW, et al. Identi-fication of ERGIC-53 as an intracellular transport receptor of a1-antitrypsin. J Cell Biol. 2008; 180(4):705-712.
31. Vollenweider F, Kappeler F, Itin C, Hauri HP. Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol. 1998; 142(2):377-389.